Beachlover, That's fine for a statement on the
Post# of 9122
That's fine for a statement on the N-Assay and what the focus is and the BNF and what the focus will not be. Anyone on a project such as what was announced Friday who is buying a TB kit from NanoLogix to USE would not be buying something that hasn't already been proven and published for TB, so that leaves the BNP TB kit that Battelle performed research on and published the results of. No N-Assay research has been published on TB. No research = no sales, no one buys unproven, period.
Here's part of the abstract from the published paper in Microbial & Biochemical Technology
Citation: Rogers JV, Choi YW (2012) Preliminary Evaluation of Mycobacterium tuberculosis Detection in Culture and Artificial Sputum Using a BioNanoPore Membrane and Real-time PCR. J Microb Biochem Technol 4: 147-151. doi:10.4172/1948-5948.1000086:
"This study demonstrates that BNP™ Middlebrook can detect M. tuberculosis faster than standard plating techniques in the presence or absence of a simulated biological matrix (artificial sputum). Moreover, the BNP™ Middlebrook color development step does not interfere with real-time PCR detection of IS 6110. This study provides a preliminary assessment of the potential use of BNP™ Middlebrook for a more rapid screening and detection of viable M. tuberculosis with respect to clinical specimen evaluation, therapeutic treatment/vaccine efficacy, or epidemiological surveillance."
This paper is all I can find on NanoLogix TB capabilities, but apparently it was interesting enough for their kits to be purchased for the third world TB project.
Scott